Related Experiment Video
Updated: Apr 15, 2026

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
The Association Between Diabetes Mellitus During Pregnancy and Retinopathy of Prematurity
Lara Saaida1, Eilon Shany1,2, Ahed Imtirat1,3
1Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.
Insights
This study found no significant link between maternal diabetes mellitus and retinopathy of prematurity in preterm infants. Further research is needed to understand risk factors for this condition.
Area of Science:
- Neonatalogy
- Ophthalmology
- Endocrinology
Background:
- Retinopathy of prematurity (ROP) is a significant cause of visual impairment in preterm infants.
- Diabetes mellitus (DM) in pregnancy is a growing concern, and its potential impact on ROP requires investigation.
Purpose of the Study:
- To evaluate the association between maternal diabetes mellitus (DM) and the development of retinopathy of prematurity (ROP).
- To identify risk factors for ROP in preterm infants born to mothers with and without DM.
Main Methods:
- Retrospective nested case-control study of preterm infants (<32 weeks gestation or <1500 g birthweight) between 2013-2021.
- Infants were grouped by ROP status; multivariable Generalized Estimating Equations (GEE) analyzed the association between ROP and maternal DM, adjusting for confounders.
- Confounders included maternal age, diabetes type, gestational age, birthweight, oxygen duration, antenatal corticosteroids, and birth plurality.
Main Results:
- The study included 881 mother-infant pairs; 39.1% of infants developed ROP.
- Maternal DM was diagnosed in 6.4% of mothers in the ROP group versus 9.7% in the control group (p=0.082).
- ROP was significantly associated with oxygen treatment, low birthweight (<1250 g), and advanced maternal age. Antenatal corticosteroids showed a protective effect.
Conclusions:
- No statistically significant association was found between maternal diabetes mellitus and the risk of retinopathy of prematurity in this cohort.
- Findings suggest other factors like oxygen exposure and birthweight are more critical in ROP development.
- Cautions regarding the retrospective design and limited glycemic control data are noted.
Abstract:
Background/Objectives: We aimed to evaluate the association between diabetes mellitus (DM) during pregnancy and retinopathy of prematurity (ROP) in preterm infants younger than 32 gestational weeks or infants with low birthweight (<1500 g). Methods: We conducted a retrospective nested case-control study of all premature infants who were born alive and survived the post-delivery hospitalization period in Soroka Medical Center, with either gestational age younger than 32 weeks or birthweight less than 1500 g, during the years 2013-2021. The infants were divided into two groups according to ROP status. Multivariable Generalized Estimating Equations (GEE) were used to analyze the association between ROP and DM, adjusting for potential confounders, including maternal age, diabetes type (GDM vs. pre-gestational DM), gestational age, birthweight (<1250 g), duration of oxygen supplementation, antenatal corticosteroid courses, and birth plurality. Results: During the study period, there were 881 pairs of women and newborns who met the inclusion criteria. The ROP group included 345 infants (39.1%). Twenty-two (6.4%) of the mothers in the ROP group were diagnosed with DM during pregnancy compared with 52 of 536 (9.7%) in the control group (p = 0.082). ROP was associated with oxygen treatment (OR 1.05; 95% CI, 1.03-1.08; p < 0.001), birthweight < 1250 g (OR 2.70; 95% CI, 1.93-3.78; p < 0.001) and advanced maternal age (OR 1.04; 95% CI, 1.01-1.06; p = 0.006). Prenatal steroid treatment was identified as a significant protective factor against ROP (OR 0.73; 95% CI, 0.60-0.89; p = 0.002). No statistically significant association was observed between maternal DM and ROP (OR 0.62; 95% CI 0.34-1.13; p = 0.12). These findings should be interpreted cautiously given the retrospective design and the limited availability of glycemic control data. Conclusions: Maternal diabetes mellitus was not significantly associated with the risk of ROP in this cohort.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Teratogenicity
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:

